print small

Participating Countries:

Australia

Austria

Belgium

Bulgaria

Canada

Cyprus

Czech Republic

Denmark

European Commission

France

Germany

Greece

Hungary

Ireland

Israel

Italy

Norway

Poland

Portugal

Romania

Russian Federation

Serbia

Slovakia

Slovenia

Spain

Sweden

Switzerland

Turkey

Ukraine

United Kingdom

United States of America

COST is supported by the EU Framework Programme Horizon 2020
This website is supported by COST
8/9/2017 (Added to site)
 Author(s): Miss Roxanne Hachani , Prof. Martin Birchall , Prof. Mark Lowdell , Mr. Georgios Kasparis , Dr. Le D. Tung , Dr. Bella Manshian , Dr. Stefaan Soenen , Dr. Willy Gsell , Prof. Uwe Himmelreich , Dr. Codi Gharagouzloo , Prof. Srinivas Sridhar, Prof. Nguyen Thi Kim Thanh

Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging

Journal: Scientific reports
DOI: 10.1038/s41598-017-08092-w

 

Stem cell tracking in cellular therapy and regenerative medicine is an urgent need, superparamagnetic iron oxide nanoparticles (IONPs) could be used as contrast agents in magnetic resonance imaging (MRI) that allows visualization of the implanted cells ensuring they reach the desired sites in vivo. Herein, we report the study of the interaction of 3,4-dihydroxyhydrocinnamic acid (DHCA) functionalized IONPs that have desirable properties for T2 weighted MRI, with bone marrow-derived primary human mesenchymal stem cells (hMSCs). Using the multiparametric high-content imaging method, we evaluate cell viability, formation of reactive oxygen species, mitochondrial health, as well as cell morphology and determine that the hMSCs are minimally affected after labelling with IONPs. Their cellular uptake is visualized by transmission electron microscope (TEM) and Prussian Blue staining, and quantified using an iron specific colourimetric method. In vitro and in vivo studies demonstrate that these IONPs are biocompatible and can produce significant contrast enhancement in T2-weighted MRI. IONPs are detected in vivo as hypointense regions in the liver up to two weeks post injection using 9.4 T MRI. These DHCA functionalized IONPs are promising contrast agents for stem cell tracking by T2-weighted MRI as they are biocompatible and show no evidence of cytotoxic effects on hMSCs.

 


Keywords: imaging    interactions    iron oxide    nanoparticles   

Founding Members

Project Office

STSM

Working Groups



Subscribe to newsletter

Subscribe